JAGX Jaguar Health, Inc. Quick Ratio

The price history on the Jaguar Health, Inc. (JAGX) chart demonstrates the dynamics of an asset whose value is currently 0.41. Jaguar Health, Inc. (JAGX) develops unique plant-based treatments to combat diarrhea in cancer patients and individuals with HIV. The implementation of AI and automated raw material control is accelerating the release of new products. However, a liquidity shortage persists, as revenue growth lags behind the pace of operating expenses.

JAGX: Jaguar Health Inc Intermediate Coverage Ratio 07/04/2022 - 10/31/2026

Summary analytical data breakdowns for jaguar.health (JAGX)

- market value and analyst target forecast:

Price Chart Jaguar Animal Health|JAGX - Consensus Target

- market capitalization data:

Market Capitalization Jaguar Animal Health|JAGX - Enterprise Value

- balance sheet net asset value indicators:

Accounting Value per Share Jaguar Health|JAGX - Accounting Value of Company|Market Capitalization to Book Value Ratio jaguar.health|JAGX - Company Balance Sheet Assets

- debt and liquidity data:

Total Debt to Capital Jaguar Health, Inc.|JAGX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Jaguar Health|JAGX - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Jaguar Animal Health|JAGX - Amount of Long-Term Liabilities|Company Short-Term Debts Jaguar Health|Quick Ratio jaguar.health

- earnings and valuation multiples information:

JAGX - Annual Net Income

Fundamental company valuation:Jaguar Health, Inc.

Flagship merchandise of Jaguar Health Inc

Jaguar Health, Inc. (JAGX) is implementing AI platforms and raw material control automation to accelerate the time-to-market for its drugs. This indicator assesses the company's ability to settle short-term debts using cash and accounts receivable, completely ignoring low-liquidity inventory. Investors analyze this parameter to identify the business's dependence on expensive external financing. The trend in the acid-test ratio makes it possible to distinguish a temporary influx of funds from systemic capital depletion.

Competitor analysis for Jaguar Health, Inc.